Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Cerenics licenses new treatment of aortic valve stenosis

Cerenis Therapeutics, a pharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, has licensed intellectual property supporting an HDL-therapy based investigational treatment of aortic valve stenosis (AVS).

Circulation: Heart rhythm abnormality predicts sudden cardiac death

Researchers have discovered that a specific heart rhythm abnormalityidiopathic QT interval prolongationincreased the risk of sudden cardiac death five-fold among patients with coronary artery disease, according to a study published online this week in Circulation.

Daschle bows out of HHS nomination

Former Senator Tom Daschle, President Barack Obama's nominee for secretary of the Department of Health and Human Services (HHS), has withdrawn from consideration for the post over his belated payment of $128,000 in federal taxes.

Invatec inks distribution deal with Lumen

Invatec, a provider of interventional products, has entered a global distribution agreement with Lumen Biomedical to distribute the FiberNet Embolic Protection System (EPS), which is indicated for the treatment of patients receiving endovascular intervention for carotid artery disease.

Critical Care: Genetic variant predicts poor response to bypass surgery

A variant of the gene for the inflammatory modulator interleukin (IL)-18 has been found to be associated with a prolonged ICU stay after cardiopulmonary bypass surgery. The study, published online in January in BioMed Central's journal Critical Care, links the TT genotype of the IL-18 9545 T/G polymorphism with a larger pro-inflammatory response.

CMAJ: PPIs increase risk of heart attacks for patients on clopidogrel

Patients taking clopidogrel following a heart attack are at a significantly higher risk of a recurrence if they are also taking acid-lowering medications such as proton pump inhibitors (PPIs), according to a study published online in January in the Canadian Medical Association Journal.

Forest Labs income narrows for Q3

Forest Laboratories has reported that its fiscal third quarter of 2009 net income was $187.98 million,a downturn compared with the $301.8 million reported in the third quarter of the prior fiscal year.

Baxter sees double-digit growth in Q4, 2008

Baxter International has reported 2008 fourth quarter net income of $569 million, an increase of 19 percent from the $478 million reported in the fourth quarter of 2007.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.